Mollie Jacobs

Mollie Jacobs is an experienced professional in the field of protein development and manufacturing, currently serving as the Associate Director of Downstream Development at Vaxcyte since February 2023. Prior roles include Principal Scientist and Senior Scientist in Viral Vector Biology at 64x Bio from November 2021 to February 2023, and Lab Leader Scientist at Denali Therapeutics from April 2019 to November 2021. Mollie also held scientist positions at Audentes Therapeutics and Thermo Fisher Scientific, as well as being a Postdoctoral Fellow at Stanford University School of Medicine, where research focused on insulin signaling and microfluidics. Education includes a Ph.D. in Biochemistry and Molecular Biology, as well as a Bachelor of Science in Microbiology and Cell Science, both from the University of Florida.